Abstract

Background: Parkinson’s disease (PD) is a chronic neurodegenerative disease that implies a progressive and invalidating functional organic disorder, which continues to evolve till the end of life and causes different mental and physical alterations that influence the quality of life of those affected. Objective: To determine the relationship between motor and nonmotor symptoms and the quality of life of persons with PD. Methods: An analytic, descriptive, cross-sectional study was conducted with patients with different degrees of PD in the Albacete Health district. The estimated sample size required was 155 patients. The instruments used for data collection included a purpose-designed questionnaire and “Parkinson’s Disease Questionnaire” (PDQ-39), which measures eight dimensions and has a global index where a higher score indicates a worse quality of life. A descriptive and bivariate analysis was conducted (SPSS® IBM 24.0). Ethical aspects: informed consent and anonymized data. Results: A strong correlation was found between the number of motor and nonmotor symptoms and global health-related quality of life and the domains mobility, activities of daily living, emotional well-being, cognitive status, and pain (p < 0.05). Receiving pharmacological treatment and taking more than four medicines per day was significantly associated with a worse quality of life (p < 0.05). Patients who had undergone surgical treatment did not show better global quality of life (p = 0.076). Conclusions: All nonmotor symptoms and polypharmacy were significantly associated with a worse global quality of life.

Highlights

  • Parkinson’s disease (PD) is the second most frequent neurodegenerative disease after Alzheimer’s disease

  • Inclusion criteria: All the patients diagnosed with PD seen by the Movement Disorders Unit who voluntarily agreed to participate in this study

  • Medication data were collected via a purpose-designed survey filled out by patients and caregivers and later verified in the clinical history

Read more

Summary

Introduction

Parkinson’s disease (PD) is the second most frequent neurodegenerative disease after Alzheimer’s disease. Its diagnosis has a considerable impact on the health-related quality of life (HRQoL). It causes around 4600 deaths annually (11th on the list of causes of death, 1.1% of the total), and its mortality rate has increased over the last two decades [1]. PD is defined by the progressive loss of dopaminergic neurons in the substantia nigra and the presence of inclusions called Lewy bodies This neuronal death leads to a dopamine deficit in the striatal endings that transmit information for the correct control of movements. Results: A strong correlation was found between the number of motor and nonmotor symptoms and global health-related quality of life and the domains mobility, activities of daily living, emotional well-being, cognitive status, and pain (p < 0.05). Conclusions: All nonmotor symptoms and polypharmacy were significantly associated with a worse global quality of life

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call